Hydroxychloroquine: a potential ethical dilemma for rheumatologists during the COVID-19 pandemic

Rosie Scuccimarri; Evelyn Sutton; Mary-Ann Fitzcharles

doi:10.3899/jrheum.200369

Research ArticleAccepted Article

Open Access

Hydroxychloroquine: a potential ethical dilemma for rheumatologists during the COVID-19 pandemic

Rosie Scuccimarri, Evelyn Sutton and Mary-Ann Fitzcharles

The Journal of Rheumatology April 2020, jrheum.200369; DOI: https://doi.org/10.3899/jrheum.200369

Rosie Scuccimarri

From the Division of Pediatric Rheumatology, McGill University Health Centre, Quebec, Canada;Division of Rheumatology, Dalhousie University, Nova Scotia, Canada; Alan Edwards Pain Management Unit, McGill University Health Centre, Quebec, Canada; Division of Rheumatology, McGill University Health Centre, Quebec, Canada. Address correspondence to Mary-Ann Fitzcharles, Montreal General Hospital, McGill University Health Centre, 1650 Cedar ave, Montreal, Quebec, H3G 1A4. E-mail:mfitzcharles@sympatico.ca

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Evelyn Sutton

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Mary-Ann Fitzcharles

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
References
Info & Metrics
PDF
eLetters

PreviousNext

Abstract

Two antimalarial agents, chloroquine (CQ) and hydroxychloroquine (HCQ), have been trusted treatments for a range of rheumatic diseases over the past seventy years [1]. These agents have attracted intense media attention in the past few weeks with suggestions that this category of drugs may have potential in the management of coronavirus (SARS-CoV2) associated disease called COVID-19 [2, 3].

PreviousNext

In this issue

The Journal of Rheumatology

Vol. 47, Issue 11

1 Nov 2020

Table of Contents
Table of Contents (PDF)
Index by Author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Hydroxychloroquine: a potential ethical dilemma for rheumatologists during the COVID-19 pandemic

Message Subject (Your Name) has forwarded a page to you from The Journal of Rheumatology

Message Body (Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

Accepted manuscript